Latest research report on “Epinephrine Autoinjector Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5552944
Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through a prescription by doctors. Each prescription comes with two auto-injectors in a set.
Epinephrine auto-injector is an emergency injection (“shot”) of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
This report contains market size and forecasts of Epinephrine Autoinjector in global, including the following market information:
Global Epinephrine Autoinjector Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Epinephrine Autoinjector Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Epinephrine Autoinjector companies in 2021 (%)
The global Epinephrine Autoinjector market was valued at 2223.6 million in 2021 and is projected to reach US$ 3500.8 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.30 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epinephrine Autoinjector include Mylan, Sanofi, ALK Abello and Impax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epinephrine Autoinjector manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epinephrine Autoinjector Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Autoinjector Market Segment Percentages, by Type, 2021 (%)
– 0.30 mg
– 0.15 mg
Global Epinephrine Autoinjector Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Autoinjector Market Segment Percentages, by Application, 2021 (%)
– Under 6 Years
– 6 to 12 Years
– Over 12 Years
Global Epinephrine Autoinjector Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epinephrine Autoinjector Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Epinephrine Autoinjector revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Epinephrine Autoinjector revenues share in global market, 2021 (%)
Key companies Epinephrine Autoinjector sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Epinephrine Autoinjector sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– ALK Abello
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5552944
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441